From Optogenetic Technologies to Neuromodulation Therapies-Reference-Cited by-同舟云学术

From Optogenetic Technologies to Neuromodulation Therapies

Published:2013-03-20 Issue:177 Volume:5 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Williams Justin C.¹,Denison Timothy²

Affiliation:

1. Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, WI 53706, USA.

2. Medtronics, Minneapolis, MN 55410, USA.

Abstract

Translating optogenetic technologies into the clinic will encounter a number of technical, practical, and regulatory hurdles.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference17 articles.

1. Electrical stimulation as therapy for neurological disorders

2. Optogenetics and Translational Medicine

3. Gene therapy clinical trials worldwide to 2007—an update

4. U.S. Food and Drug Administration Center for Biologics Evaluation and Research November 2006 Guidance for Industry: Gene Therapy Clinical Trials—Observing Subjects for Delayed Adverse Events ; www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm078719.pdf.

5. Gene therapy: a viable therapeutic strategy for Parkinson’s disease?

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closed-loop optogenetic neuromodulation enables high-fidelity fatigue-resistant muscle control;Science Robotics;2024-05-22

2. Deep brain stimulation in Parkinson’s disease: A scientometric and bibliometric analysis, trends, and research hotspots;Medicine;2024-05-17

3. Dynamic modeling of neuromodulation techniques: Towards elaboration and individual specificity;Europhysics Letters;2024-02-01

4. Wearable and Implantable Light-Emitting Diodes and Their Biomedical Applications;Korean Journal of Chemical Engineering;2024-01

5. Bioadhesive Technology Platforms;Chemical Reviews;2023-11-16